HSPA5 and Zygomycosis: Therapeutic intervention with either anti-CotH or anti-GRP78 antibodies protects neutropenic and diabetic ketoacidosis mice against mucormycosis, highlighting the significance of CotH/ GRP78 protein interactions in the pathophysiology of mucormycosis [69,70,85].